PTX
Prescient Therapeutics Ltd
APAC company
Healthcare
Biotechnology
/
NAV Price
-
Last Traded
-
Chg
-
-
XASX
-
Updated: -
Times are shown in GMT+11, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
/
Company Profile
Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.Prescient Therapeutics Ltd is a clinical stage oncology company engaged in developing & commercialising novel products to improve standard cancer treatments.
ASX:PTX
AU000000PTX3
AUD
Loading Comparison
Latest PTX News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News